How often should you really get a skin check?

July 15, 2026 · William S. Farmer, MD

If you search this question, nearly every answer says the same thing: once a year. It’s clean, it’s memorable, and it’s not really what the evidence says.

The honest answer is that skin check frequency isn’t one number. It’s a range, and where you land in that range depends on your own risk – your history, your skin, your family, your medications. Some people genuinely benefit from being seen every three months. Many healthy adults with no risk factors have never been shown to benefit from routine screening at all. Most people are somewhere in between.

Here’s how that decision actually gets made.

The “insufficient evidence” finding, and why it applies to almost no one

You may have heard that the evidence for routine skin cancer screening is “insufficient.” That’s true, as far as it goes – but it’s a much narrower and stranger finding than it sounds, and worth understanding rather than taking at face value.

The U.S. Preventive Services Task Force reviews preventive care specifically for asymptomatic people, and its definition of asymptomatic is stricter than you’d guess. To qualify, a person needs: no signs of skin cancer, no symptoms, no personal history of skin cancer, no family history of skin cancer, no changes in the size, shape, or color of any skin growth, and no irregular moles.

Read that list again. Almost no real adult clears all six bars. Most people have had a mole change at some point, or have a relative who’s had a skin cancer, or have noticed something they wondered about. The recommendation, as written, applies to a genuinely blank slate that very few people actually are.

There’s also a logical wrinkle worth naming: telling an actual sign of skin cancer apart from a normal skin variation takes medical training. Asking someone to self-certify as “asymptomatic” before deciding whether they need an evaluation asks them to make the exact judgment the evaluation exists to make.

So why “insufficient evidence” rather than a clear yes or no? Largely because the task force is committed to recommendations that hold up across every population – including the full range of skin tones – and skin cancer research on non-white skin is thin. Its most recent review drew on three non-randomized screening studies, all conducted in Germany – not an especially close stand-in for the U.S. population – plus nine studies linking later-stage melanoma diagnosis to worse outcomes, which speaks to the value of catching things early but isn’t a study of screening itself. On potential harms, there were two small studies. That’s a thin evidence base to draw a firm conclusion from in either direction, and the task force says as much, closing with a direct handoff: “Clinicians should use their judgement when deciding whether to screen for skin cancer.” [1]

That’s a familiar pattern for the task force, not a one-off. Some things are hard to study with a randomized trial not because they don’t matter, but because withholding them from a control group to test them would be unethical – car seats for children carry a surprisingly similar evidence rating, for exactly this reason. “We don’t have the randomized trial” and “this doesn’t work” are not the same statement, and the difference matters here.

The American Cancer Society recommends a monthly self-examination for everyone [2], which is a reasonable habit regardless of your risk level. The American Academy of Dermatology, notably, doesn’t specify a screening frequency at all [3] – and part of why is worth knowing: the back is the single most common site for melanoma, and it’s one of the hardest places to examine on yourself. Self-checks matter, but they have a real blind spot, which is part of why a professional set of eyes still has a role even before you’ve noticed anything wrong yourself.

Put differently: “should we screen the entire population on a fixed schedule?” and “should you be checked, given your history?” are different questions with different answers. The second one is the one that matters in the exam room.

The risk factors that actually move the number

These are what shift someone from “probably doesn’t need routine screening” toward “should be seen regularly.” Dermatology’s own clinical guidelines – including NCCN’s cancer-specific guidelines [5] and the Mohs Surgery Appropriate Use Criteria [6] – draw on a similar set of history-based factors to decide how closely to evaluate and treat, which is part of why personal history carries so much weight in this conversation:

• A previous skin cancer. The single strongest predictor of a future skin cancer is having had one. This is the factor that most reliably lands people on a set schedule.
• A family history of skin cancer, particularly in a first-degree relative, and especially if more than one. It’s also worth mentioning a family history of any cancer to your dermatologist, not only skin cancer – some inherited genetic changes run in families without following just one pattern, raising one relative’s risk of breast or other cancers while raising a different relative’s risk of skin cancer.
• A high mole count, or atypical moles. This matters more than people expect: having 50 to 100 moles is associated with roughly triple the typical risk, and more than 100 moles raises it further still. [4] Moles that are irregular, changing, or that a dermatologist has previously flagged also count here.
• Fair skin that burns rather than tans, light eyes, red or blond hair.
• A history of significant sun exposure. This covers more ground than people expect:
  • Sunburns, especially any that blistered, particularly in childhood
  • Tanning bed use, at any point in your history
  • Where you’ve lived – time in the southern U.S., the Southwest, at high altitude, in Hawaii, the tropics, or anywhere closer to the equator all add up to more lifetime UV exposure
  • Sun-exposed work – construction, roofing, farming, lifeguarding, firefighting, postal or delivery work, military service, or truck driving
  • Sun-exposed hobbies – golf, fishing, boating, time at the beach, and water or snow skiing (snow reflects UV back at you, so it counts even in winter)
• Older age and male sex – two factors the USPSTF’s own review lists as raising risk. [1]
• Smoking, and certain occupational or environmental chemical exposures, including Agent Orange exposure.
• Immunosuppression, from any cause. This one deserves emphasis, because it’s the most underappreciated. Organ transplant recipients on long-term immunosuppression have a substantially higher risk of squamous cell carcinoma than the general population, and those cancers tend to behave more aggressively. The same principle applies to causes people don’t always connect to skin risk: chemotherapy or immunotherapy for another cancer, long-term immunosuppressive medication for an autoimmune or inflammatory condition, and certain viral illnesses that weaken immune function. If your immune system is or has been suppressed for any reason, it’s worth mentioning specifically.
• Prior radiation therapy, or certain inherited conditions that affect the skin’s ability to repair sun damage.
• Pre-cancers already present (actinic keratoses and dysplastic nevi) – a marker that the skin has accumulated meaningful sun damage.

None of these is a verdict on its own. They’re inputs. Two of them together matters more than one alone.

So what does the schedule actually look like?

Roughly, and with the caveat that this is exactly the kind of thing that should be individualized rather than read off a chart:

Someone with no risk factors and no concerning spots may not need a fixed schedule, but I would still recommend being seen once. A single visit is what turns I think I am low risk into an actual assessment, made by someone who has examined your skin rather than by you. It is also where a schedule gets set, if you turn out to need one.

There is a quieter reason too. Deciding you are low risk requires already knowing what low risk looks like, and that is exactly what the visit provides. It can genuinely be hard to know what you’re looking for on a self-exam, and harder still to see your entire body. On cost, it is worth checking what your insurance covers: many plans include an annual preventive visit at no added cost, which makes a first visit more accessible than people assume.

Which brings us to the most important line in this post: a new or changing spot is not screening. If you’ve noticed something, that’s not a routine check, that’s an evaluation, and it shouldn’t wait for an annual slot.

Someone with meaningful risk factors – fair skin plus heavy sun history, a strong family history, a high mole count – is commonly seen annually.

Someone with a personal history of skin cancer is typically seen on a set schedule that follows national guidelines: every six months after a basal cell or squamous cell carcinoma, and every three months after a melanoma diagnosis. [5] After a couple of years without anything new turning up, that frequency can often space back out.

Someone on long-term immunosuppression, especially a transplant recipient, is often seen every three to six months, because both the risk and the aggressiveness of skin cancers are higher in this group.

The point of listing these isn’t so you can self-assign. It’s so the recommendation you get makes sense to you.

What you should be doing between visits

Whatever your schedule, the checks that catch things earliest are usually the ones you do yourself. You see your skin far more often than any dermatologist will.

You don’t need a method so elaborate you abandon it by March. Once a month, in good light, look yourself over – and get help for the places you can’t see well, particularly your back and scalp. What you’re looking for isn’t a particular shape. It’s change, and it’s difference: a spot that’s evolving, or a spot that doesn’t look like your other spots. (That second one – the “ugly duckling” – is often more useful than any checklist, and it now has its own post.) A simple habit that helps: photograph any spot you’re keeping an eye on and save it. A photo from six months ago is a far better comparison than memory, and it gives your dermatologist something concrete to look at too.

Anything new, changing, bleeding, or not healing deserves a look. That’s true no matter when your last visit was.

The real answer

How often should you get a skin check? As often as your risk warrants – which might be never on a fixed schedule, might be every three months, and for most people falls somewhere in between.

That’s a less satisfying answer than “once a year.” Here’s what I’d actually tell you, if a range isn’t concrete enough to act on: you aren’t a population, so a population-level answer was never going to be the right one for you individually. Get an individual one instead. If you’ve never had a proper skin check, go get one from a dermatologist – report every risk factor above at that visit, even the ones that feel minor, and ask directly for an opinion based on your specific case. If you’ve already had one and have a recommended frequency, follow it. Either way, come in any time you notice something new or changing, no matter where you are in that schedule.

Keep up your own self-exams in the meantime – but use them only to flag something new or different, never to diagnose it yourself. That part is our job, not yours.

That’s the individualized conversation worth having – not a number pulled from a search result.

References

1. US Preventive Services Task Force. Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;329(15):1290-1295. doi:10.1001/jama.2023.4342
2. American Cancer Society. Skin Cancer: What You Need to Know About Melanoma and Other Skin Cancers. cancer.org.
3. American Academy of Dermatology Association. Skin Cancer Types: Melanoma – Warning Signs and Images. aad.org.
4. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, Melchi CF. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. European Journal of Cancer. 2005;41(1):28-44. doi:10.1016/j.ejca.2004.10.015. PMID: 15617989
5. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Cutaneous Melanoma; Basal Cell Skin Cancer; Squamous Cell Skin Cancer. NCCN.org.
6. Connolly SM, Baker DR, Coldiron BM, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery. J Am Acad Dermatol. 2012;67(4):531-550. doi:10.1016/j.jaad.2012.06.009

Magnolia Forge Dermatology is coming to Raleigh, North Carolina. We are not yet scheduling appointments.

Medical content: William S. Farmer, MD · Last reviewed: July 2026